Indications and uses
temporarily protects and helps relieve chapped or cracked lips helps prevent sunburn
temporarily protects and helps relieve chapped or cracked lips helps prevent sunburn
apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially ...
protect the product in this container from excessive heat and direct sun
DEEP RENEWAL®
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Avobenzone 3.0% (w/w) | Sunscreen |
| Dimethicone 2.0% (w/w) | Lip protectant |
| Octinoxate 7.5% (w/w) | Sunscreen |
| Octocrylene 2.7% (w/w) | Sunscreen |
| Oxybenzone 2.5% (w/w) | Sunscreen |
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs.
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
atelocollagen, beeswax, butylene glycol, dipalmitoyl hydroxyproline, ethylhexyl palmitate, flavor, jojoba esters, lanolin alcohol, microcrystalline wax, octyldodecanol, pentaerythrityl tetraisostearate, petrolatum, phenoxyethanol, polybutene, polyethylene, PTFE, ricinus communis (castor) seed oil, saccharin, silica dimethyl silylate, sodium chondroitin sulfate, sodium hyaluronate, sorbic acid, squalane, tetrahexyldecyl ascorbate, tocopheryl acetate, ubiquinone
SILK & SHINE®
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Dimethicone 2.0% (w/w) | Lip protectant |
| Octinoxate 7.5% (w/w) | Sunscreen |
| Oxybenzone 2.5% (w/w) | Sunscreen |
Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
arachidyl alcohol, arachidyl glucoside, behenyl alcohol, bis-diglyceryl polyacyladipate-2, flavors, hydrogenated polyisobutene, isostearoyl hydrolyzed silk, mica, microcrystalline wax, mineral oil, ozokerite, panthenyl ethyl ether, paraffin, pentaerythrityl tetraethylhexanoate, petrolatum, phenoxyethanol, phenyl trimethicone, polybutene, PPG-5-Ceteth-20, saccharin, titanium dioxide, tocopheryl acetate
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10157-9865-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-3a48-f424-e053-dadaa90a57ce | Blistex ® Enhancement Series ® (Deep Renewal ® and Silk & Shine ® ) |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9865-1 | Blistex Enhancement Series (Deep Renewal and Silk and Shine) | 1 in 1 BLISTER PACK | KIT | 1 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9865 | BLISTEX ENHANCEMENT SERIES (DEEP RENEWAL AND SILK AND SHINE) (AVOBENZONE, DIMETHICONE, OCTINOXATE, OCTOCRYLENE AND OXYBENZONE) KIT [BLISTEX INC.] | 1 | Legacy NDC, 1 package rows | 20150201_44fb78ec-460c-4743-975a-92174b26a0fc.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| Dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Oxybenzone | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| Dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| Oxybenzone | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| arachidyl alcohol | INACTIVE INGREDIENT | 1QR1QRA9BU | 1 | |
| arachidyl glucoside | INACTIVE INGREDIENT | 6JVW35JOOJ | 1 | |
| butylene glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| castor oil | INACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| Ceresin | INACTIVE INGREDIENT | Q1LS2UJO3A | 1 | |
| CHONDROITIN SULFATE SODIUM (SHARK) | INACTIVE INGREDIENT | Q75WVO004L | 1 | |
| dipalmitoyl hydroxyproline | INACTIVE INGREDIENT | E6AHA53N1H | 1 | |
| docosanol | INACTIVE INGREDIENT | 9G1OE216XY | 1 | |
| ethylhexyl palmitate | INACTIVE INGREDIENT | 2865993309 | 1 | |
| high density polyethylene | INACTIVE INGREDIENT | UG00KM4WR7 | 1 | |
| hyaluronate sodium | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| lanolin alcohols | INACTIVE INGREDIENT | 884C3FA9HE | 1 | |
| MARINE COLLAGEN, SOLUBLE | INACTIVE INGREDIENT | 8JC99XGU4W | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| microcrystalline wax | INACTIVE INGREDIENT | XOF597Q3KY | 1 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | 1 | |
| octyldodecanol | INACTIVE INGREDIENT | 461N1O614Y | 1 | |
| panthenyl ethyl ether | INACTIVE INGREDIENT | F4WMF8NX3B | 1 | |
| paraffin | INACTIVE INGREDIENT | I9O0E3H2ZE | 1 | |
| pentaerythrityl tetraethylhexanoate | INACTIVE INGREDIENT | XJ7052W897 | 1 | |
| pentaerythrityl tetraisostearate | INACTIVE INGREDIENT | 9D7IK5483F | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| phenyl trimethicone | INACTIVE INGREDIENT | DR0K5NOJ4R | 1 | |
| Polybutene (1400 MW) | INACTIVE INGREDIENT | 1NA5AO9GH7 | 1 | |
| polytetrafluoroethylene | INACTIVE INGREDIENT | E1NC1JVS3O | 1 | |
| PPG-5-Ceteth-20 | INACTIVE INGREDIENT | 4AAN25P8P4 | 1 | |
| saccharin | INACTIVE INGREDIENT | FST467XS7D | 1 | |
| sandalwood | INACTIVE INGREDIENT | 3641YW25N2 | 1 | |
| silica dimethyl silylate | INACTIVE INGREDIENT | EU2PSP0G0W | 1 | |
| SIMMONDSIA CHINENSIS SEED WAX | INACTIVE INGREDIENT | 47X6Y9FJJ2 | 1 | |
| sorbic acid | INACTIVE INGREDIENT | X045WJ989B | 1 | |
| squalane | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| tetrahexyldecyl ascorbate | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| titanium dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| UBIDECARENONE | INACTIVE INGREDIENT | EJ27X76M46 | 1 | |
| yellow wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10157-9865 | 10157-9865-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| octyldodecanol | OCTYLDODECANOL | 461N1O614Y | CREAM / VAGINAL | 13.5 %w/w | ||
| sorbic acid | SORBIC ACID | X045WJ989B | LOTION / TOPICAL | 4 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | SYSTEM / TRANSDERMAL | NA | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| octyldodecanol | OCTYLDODECANOL | 461N1O614Y | LOTION / TOPICAL | 714 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | FILM, EXTENDED RELEASE / TRANSDERMAL | 85 mg | ||
| saccharin | SACCHARIN | FST467XS7D | DROPS / ORAL | 20 mg/1ml | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | TABLET, SUGAR COATED / ORAL | NA | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | PASTE / TOPICAL | 2.5 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GUM, CHEWING / BUCCAL | 182 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET, DELAYED RELEASE / ORAL | 0.03 mg | ||
| Ceresin | CERESIN | Q1LS2UJO3A | CREAM / VAGINAL | 280 mg | ||
| saccharin | SACCHARIN | FST467XS7D | POWDER, DENTIFRICE / DENTAL | NA | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | TABLET, DELAYED RELEASE / ORAL | 0.1 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | EMULSION / OPHTHALMIC | 1 mg | ||
| castor oil | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg | ||
| phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | TABLET / ORAL | 50 mg | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| butylene glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| squalane | SQUALANE | GW89575KF9 | POWDER / ORAL | 0.02 mg | ||
| squalane | SQUALANE | GW89575KF9 | AEROSOL, FOAM / TOPICAL | 2.23 %w/w | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| silica dimethyl silylate | SILICA DIMETHYL SILYLATE | EU2PSP0G0W | SUSPENSION / ORAL | 120 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | CAPSULE, EXTENDED RELEASE / ORAL | 4.53 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | OINTMENT / OPHTHALMIC | NA | ||
| saccharin | SACCHARIN | FST467XS7D | TABLET / SUBLINGUAL | 0.2 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, LIQUID FILLED / ORAL | 12 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| castor oil | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| lanolin alcohols | LANOLIN ALCOHOLS | 884C3FA9HE | OINTMENT / TOPICAL | 452 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Polybutene (1400 MW) | POLYBUTENE (1400 MW) | 1NA5AO9GH7 | SYSTEM / TRANSDERMAL | 17.87 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | SYRUP / ORAL | 80 mg | ||
| lanolin alcohols | LANOLIN ALCOHOLS | 884C3FA9HE | CREAM / TOPICAL | 6 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | LOTION / TOPICAL | NA | ||
| octyldodecanol | OCTYLDODECANOL | 461N1O614Y | CREAM / TOPICAL | 160 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| sorbic acid | SORBIC ACID | X045WJ989B | TABLET / ORAL | 10 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | TABLET / ORAL | 113.75 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | OINTMENT / TOPICAL | 5 %w/w | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER, FOR SUSPENSION / ORAL | 297 mg | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| castor oil | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| hyaluronate sodium | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| mineral oil | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| hyaluronate sodium | HYALURONATE SODIUM | YSE9PPT4TH | INJECTION, SUSPENSION / INTRAMUSCULAR | 23 mg | ||
| high density polyethylene | HIGH DENSITY POLYETHYLENE | UG00KM4WR7 | OINTMENT / TOPICAL | 94 %w/w | ||
| Polybutene (1400 MW) | POLYBUTENE (1400 MW) | 1NA5AO9GH7 | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED PELLETS / ORAL | 4.4 mg | ||
| titanium dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0cd06a11-ddec-4cab-91de-086cdbbb1b73 | 44fb78ec-460c-4743-975a-92174b26a0fc | 2014-12-05 | Warnings | 0cd06a11-ddec-4cab-91de-086cdbbb1b73 44fb78ec-460c-4743-975a-92174b26a0fc |
Adverse event summaries are temporarily unavailable. Other product information remains available.